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Background/Aims
Patients with untreated achalasia frequently complain of heartburn and regurgitation. The diagnosis of achalasia might be delayed 
because these symptoms are misinterpreted as gastroesophageal reflux. We aim to evaluate the clinical, radiologic, and manometric 
findings in patient with untreated achalasia.
Methods
The records of patients diagnosed with primary achalasia between July 2004 and January 2012 at Gangnam Severance Hospital, 
Seoul, Korea were evaluated. We reviewed their clinical history and the findings of barium esophagogram, upper gastrointestinal 
endoscopy, and esophageal transit scintigraphy. We also compared the clinical, radiologic, and manometric findings of patients 
according to heartburn symptoms and proton pump inhibitor use.
Results
Our study included a total of 64 patients with a median age of 44.5 (interquartile range, 31.5-54.0). The median duration of 
symptoms was 23.5 (interquartile range, 5.3-57.0) months. Sixty-four patients (100%) had dysphagia, 49 (76.6%) had regurgitation, 
35 (54.7%) had chest pain, and 38 (59.4%) had heartburn. Typical clinical features of gastroesophageal reflux disease (GERD) such 
as regurgitation, heartburn, and chest pain were observed in more than 50% of achalasia patients. Proton pump inhibitors were 
prescribed for 16 patients (25%) on the assumption that they had GERD. Patients with heartburn were more likely to experience 
weight loss (P = 0.009), regurgitation (P = 0.001), or chest pain (P = 0.019).
Conclusions
Heartburn, regurgitation, and chest pain were commonly observed in patients with untreated achalasia. Therefore, these findings 
suggest that achalasia should be suspected in patients with refractory GERD.
(J Neurogastroenterol Motil 2017;23:378-384)
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Introduction  
Achalasia is an uncommon primary esophageal motor disorder 
that is defined by lack of peristalsis in the smooth muscle esophagus 
and failed or insufficient relaxation of the lower esophageal sphinc-
ter (LES) in response to swallowing.1
Frequently, gastroenterologists in referral centers see patients 
with achalasia who were previously diagnosed with gastroesopha-
geal reflux disease (GERD) based on symptoms, but who did not 
respond to proton pump inhibitor (PPI) treatment. This is likely 
because while both disorders can present with similar symptoms, 
GERD is more common, making it the default diagnosis for a 
practitioner with limited awareness and knowledge of achalasia. In 
addition, achalasia has an insidious onset and progresses gradually, 
giving the illusion that it is a chronic but stable condition. There-
fore, patients with achalasia typically experience symptoms for years 
before diagnosis. A previous report showed that the mean duration 
of symptoms prior to diagnosis was 4.7 years in patients with newly 
diagnosed achalasia.2 The delay in diagnosis was mainly because 
typical symptoms like heartburn and regurgitation were misinter-
preted as GERD. Stasis of food with acidic content is frequently 
misunderstood as the acid regurgitation of GERD, and fermenta-
tion can cause heartburn. This leads many patients to being treated 
for GERD well before the diagnosis of achalasia is made.3 Having 
said this, it is not known how often the presence of symptoms er-
roneously leads to treatment with a PPI on the assumption that 
GERD is present.
The aim of this study is to evaluate the clinical, radiologic, and 
manometric findings of our patients with untreated achalasia.
Materials and Methods  
Patients
The clinical records of patients with achalasia at Gangnam Sev-
erance Hospital in Seoul, Korea, between July 2004 and January 
2012, were retrospectively collected. The diagnosis of achalasia was 
based on the results of clinical evaluation with barium esophagram, 
endoscopy, esophageal transit scintigraphy (ETS), and esophageal 
manometry. None of the patients had underwent previous endo-
scopic treatment (botulinum toxin injection or pneumatic dilatation) 
or surgical myotomy at the time of their evaluation for this study.
This was a retrospective study from a prospectively collected 
database. The data were stored in paper form. Questionnaires (in-
cluding dysphagia grade and the Eckardt score) were updated at 
the time of diagnosis. In particular, we checked whether patients 
were taking PPI because their primary physician had presumed 
their symptoms were caused by refractory GERD. The definition 
of refractory GERD remains controversial.4-6 Refractory GERD 
was defined as the persistence of symptoms that do not respond to 
standard dose of PPI once daily during a treatment period of at 
least 8 weeks. Patients with achalasia were excluded if they had a 
previous treatment history of botulinum toxin injection, pneumatic 
dilatation or surgical myotomy. This study had Institutional Review 
Board approval of Gangnam Severance Hospital.
Symptom Evaluation
Patients were assessed using the Eckardt score7 and dysphagia 
grade. The Eckardt score is derived from several symptom scores 
for dysphagia, regurgitation, and chest pain (0, absent; 1, occa-
sional; 2, daily; and 3, each meal), and weight loss (0, no weight 
loss; 1, < 5 kg; 2, 5-10 kg; and 3, > 10 kg). The scores from each 
symptom are summed to make a total score that ranges from 0 to 
12 points. The heartburn was categorized into 4 groups according 
to symptom frequency (0, absent; 1, occasional; 2, daily; and 3, each 
meal). The duration of symptoms was also recorded. The dysphagia 
grade was categorized into five groups according to the severity of 
the dysphagia (1 indicates dysphagia to meat; 2, to rice; 3, to semi-
solid diet; 4, to a liquid diet; and 5 to water).
Esophagram
Esophagram was performed in the erect anteroposterior 
projection, as well as the erect left posterior and anterior oblique 
fluoroscopic projections (Shimavision 2000HG; Shimadzu, Kyoto, 
Japan). The shape of the esophagus, its maximum diameter, nar-
rowing at the esophagogastric junction, and the presence of diver-
ticula were recorded. Two gastrointestinal radiologists reviewed all 
measurements, and a consensus was reached.
Esophageal Transit Scintigraphy
ETS was performed with technetium-99m after overnight fast-
ing. All ETS images were acquired using a gamma camera (Genesys 
Vertex; Adac Laboratories, CA, USA) and an anterior scan with the 
patient in the erect position. The time-radioactivity curve was made 
using the method described in a previous study.8 The time required 
for radioactivity in the esophagus to reach half of the maximum was 
defined as the half time (T1/2). The residual fraction of maximum 
radioactivity in the esophagus at 30 seconds was defined as R30 (%).
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Esophageal Manometry
Esophageal manometry was performed using an eight-channel 
water perfusion system from Synectics Medical Carsen Group 
(Washington, USA) from 2002 to 2010. After 2011, esophageal 
manometry was performed by high-resolution manometry (HRM) 
with a 21-channel manometric assembly from Sierra Scientific In-
struments (Los Angeles, CA, USA). The data were digitized and 
displayed, stored, and analyzed using Mano View analysis software 
from Sierra Scientific Instruments. Each manometry procedure was 
performed as previously described.8
Achalasia was diagnosed by conventional manometry when 
there was a lack of peristalsis in the smooth muscle esophagus and 
when failed or insufficient relaxation of the LES was present. Acha-
lasia was diagnosed by HRM when the integrated relaxation pres-
sure was 15 or greater and there was no peristalsis in the smooth 
muscle of the esophagus. Of the total number of patients in our 
study, only 47 patients had undergone esophageal manometry tests, 
39 patients of which were tested by conventional manometry, and 8 
patients by HRM.
Statistical Methods
Frequency, percentage, and median (interquartile range) were 
used as descriptive statistics. Chi-square tests or Fisher’s exact test 
were used to compare categorical variables. Continuous variables 
are presented as medians and were compared using a Mann-Whit-
ney U test. Differences were considered significant at a P-value of 
less than 0.05. All statistical analysis was performed using the Sta-
tistical Package for the Social Sciences (SPSS) 18.0 for Windows 
(IBM Corp, Armonk, NY, USA).
Results  
Patient Characteristics
This study included a total of 64 patients (36 female and 28 
male) with primary achalasia. Clinical, radiographic, and manomet-
ric data of the patients are provided in Table 1. All 64 patients had 
dysphagia, with the median dysphagia grade being 3 (2-4), and the 
median duration of symptoms was 23.5 (interquartile range, 5.3-
57.0) months. Other symptoms at the time of presentation were 
regurgitation (76.6%), chest pain (54.7%), heartburn (59.4%), and 
weight loss (68.7%). The median Eckardt score was 5 (3-7). At 
the time of referral to our center, 16 patients (25.0%) were taking 
a PPI on the assumption by the referring physician that refractory 
Table 1. Baseline Patient Characteristics
Total patients 64
Age (median [IQR], yr) 44.5 (31.5-54.0)
Duration of symptoms (median [IQR], mo) 23.5 (5.3-57.0)
Sex (female/male, n) 36 (56.3%)/28 (43.7%)
Weight loss (n)
    0 kg
    < 5 kg
    5-10 kg
    > 10 kg
20 (31.3%)
25 (39.1%)
17 (26.6%)
  2 (3.0%)
Dysphagia (n)
    No
    Occasionally
    Every day
    Several times/day
  0 (0.0%)
15 (23.4%)
21 (32.8%)
28 (43.8%)
Regurgitation (n)
    No
    Occasionally
    Every day
    Several times/day
15 (23.4%)
26 (40.7%)
18 (28.1%)
  5 (7.8%)
Chest pain (n)
    No
    Occasionally
    Every day
    Several times/day
29 (45.3%)
24 (37.5%)
  7 (10.9%)
  4 (6.3%)
Heartburn (n)
    No
    Occasionally
    Every day
    Several times/day
26 (40.6%)
27 (42.2%)
  9 (14.1%)
  2 (3.1%)
Dysphagia grade (n)
    Meat
    Rice
    Semisolid
    Liquid
    All
  4 (6.3%)
21 (32.8%)
17 (26.6%)
15 (23.4%)
  7 (10.9%)
Eckardt score (median [IQR])   5 (3-7)
Proton pump inhibitor use (n)
Esophagram (median [IQR], mm)
    Maximum diameter of the esophageal body
Manometrya (median [IQR], mmHg)
    LES pressure of conventional manometry
    LES pressure of high-resolution manometry
Esophageal scanb 
    T1/2 (median [IQR], min)
    R30 (median [IQR], %)
16 (25.0%)
44 (38-52)
44.3 (28.1-71.1)
37.1 (22.8-64.2)
22.5 (4.7-503.8)
64.0 (41.5-83.5)
aOnly 47 patients were tested by esophageal manometry (39 conventional ma-
nometry and 8 high-resolution manometry).
bFifty-seven patients were examined by esophageal scan.
IQR, interquartile range; LES, lower esophageal sphincter; T1/2, half time of 
esophageal transit scintigraphy; R30, the residual fraction of maximum radioac-
tivity in the distal esophagus after 30 seconds.
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GERD was the cause of their symptoms. Persistence of symptoms 
and poor response despite PPI therapy, and/or endoscopic findings 
not consistent with symptoms were the main indications for referral 
to our tertiary care center. Endoscopy was performed in all patients. 
No patients had Barrett’s esophagus, stricture, or cancer.
Sixty-one patients (95.3%) underwent barium esophagram. 
The other 3 patients could not hold a sufficient mouthful of barium 
to ensure adequate swallow volumes. The median maximum di-
ameter of the esophageal body was 44 mm (38-52). A dilated and 
tortuous esophagus was present in 6 patients (9.4%). Diverticulae 
were present in 2 patients (3.1%).
Forty-seven patients were diagnosed by esophageal manometry. 
Thirty-nine patients who received conventional manometry had a 
median LES pressure of 44.3 mmHg (28.1-71.1). Eight patients 
who received HRM had a median resting LES pressure of 37.1 
mmHg (22.8-64.2). The other 17 patients were diagnosed by 
barium esophagram, either because they could not tolerate the ma-
nometry catheter or because the catheter could not be placed due to 
esophageal dilatation and tortuosity of the lower esophagus.
Fifty-seven patients received ETS. The median T1/2 for esoph-
ageal emptying was 22.5 (4.7-503.8) minutes. The median R30 was 
64% (41.5-83.5%).
Comparison of Clinical, Radiographic, and Manometric 
Findings in Relation to Heartburn Symptoms
Comparison of clinical, radiographic, and manometric find-
ings according to the presence or absence of heartburn symptoms 
showed that age, sex, duration of symptoms, dysphagia, dysphagia 
grade, and PPI use were similar between the 2 groups (Table 2). 
Patients with heartburn symptoms were more likely to exhibit 
Table 2. Comparison of Clinical, Radiographic, and Manometric Profiles in Relation to Heartburn Symptoms
Heartburn symptoms
(n = 38)
No heartburn symptoms
(n = 26)
P-value
Age (median [IQR], yr) 41.0 (33.8-54.3) 47.0 (30.8-53.5) 0.848
Sex (female/male, n)
Duration of symptoms (median [IQR], mo)
19 (50.0%)/19 (50.0%)
17.5 (5.0-69.0)
17 (65.4%)/9 (34.6%)
30 (5.5-54.0)
0.223
0.768
Weight loss (n)
    < 5 kg/≥ 5 kg 22 (57.9%)/16 (42.1%) 23 (88.5%)/3 (11.5%) 0.009
Dysphagia (n)
    < Occasionally/≥ every day 7 (18.4%)/31 (81.6%) 8 (30.8%)/18 (69.2%) 0.252
Regurgitation (n)
    < Occasionally/≥ every day 18 (47.4%)/20 (52.6%) 23 (88.5%)/3 (11.5%) 0.001
Chest pain (n)
    < Occasionally/≥ every day 28 (73.7%)/10 (26.3%) 25 (96.2%)/1 (3.8%) 0.019
Proton pump inhibitor use (n) 12 (31.6%) 4 (15.4%) 0.142
Dysphagia grade (n)
    1-2/3-5 14 (36.8 %)/24 (63.2%) 11 (42.3%)/15 (57.7%) 0.660
Eckardt score (median [IQR]) 6 (4.0-7.3) 3 (2.0-4.3) < 0.001
Esophagram (median [IQR], mm)
    Maximum diameter of the esophageal body 46.0 (38.0-54.0) 40.0 (36.0-51.2) 0.206
Conventional manometry 
    LES pressure (median [IQR], mmHg)a 42.7 (25.8-57.8) 57.4 (32.3-109.2) 0.175
High-resolution manometry
    LES pressure (median [IQR], mmHg)b 43.2 (17-43.2) 31 (23.6-77) 0.881
Esophageal scanc
    T1/2 (median [IQR], min)
    R30 (median [IQR], %)
27.9 (4.3-499.5)
60 (45-76)
17.8 (4.4-1144)
66 (36.8-87.3)
0.949
0.558
aThirty-nine patients were examined by conventional manometry.
bEight patients were examined by high-resolution manometry.
cFifty-seven patients were examined by esophageal scan.
IQR, interquartile range; LES, lower esophageal sphincter; T1/2, half time of esophageal transit scintigraphy; R30, the residual fraction of maximum radioactivity in 
the distal esophagus after 30 seconds.
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weight loss ≥ 5 kg (P = 0.009), daily regurgitation (P = 0.001), 
and daily chest pain (P = 0.019). They also had a higher Eckardt 
score (P < 0.001). However, there were no statistically significant 
differences between the groups with regard to other factors.
Comparison of Clinical, Radiographic, and Manometric 
Findings in Relation to Proton Pump Inhibitor Use
We compared the clinical, radiographic, and manometric find-
ings in relation to erroneous GERD diagnosis based on the use 
of PPI on the assumption by the referring physician as refractory 
GERD (Table 3). The PPI-treated group was defined as standard 
dose of PPI once daily treatment for at least 8 weeks. There were 
no statistically significant differences between the groups for any of 
the variables tested, including duration of symptoms.
Discussion  
The major findings of our study in patients with untreated 
achalasia are as follows. First, dysphagia was the most com-
mon complaint, although regurgitation and heartburn were also 
frequently present. The prevalence of heartburn in our patients 
with achalasia was 59.4%, which is higher than that reported else-
where.9-11 It is generally thought that the diagnosis of GERD can 
be reliably made on the basis of clinical symptoms: if a patient has 
heartburn or regurgitation it is assumed that acid reflux is present, 
and therefore a PPI is prescribed. However, symptoms are less 
sensitive and specific than commonly believed. A previous study 
showed that symptoms alone cannot distinguish real GERD from 
Table 3. Comparison of Clinical, Radiographic, and Manometric Profiles in Relation to Proton Pump Inhibitor Use
PPI-treated groupa
(n = 16)
PPI untreated group
(n = 48)
P-value
Age (median [IQR], yr) 41.5 (35.3-56.3) 45.5 (31-53.8) 0.614
Sex (female/male, n [%])
Duration of symptoms (median [IQR], mo)
6 (37.5%)/10 (62.5%)
11 (6.26-33)
30 (62.5%)/18 (37.5%)
24 (5-90)
0.080
0.469
Weight loss (n)
    < 5 kg/≥ 5 kg 12 (75%)/4 (25%) 33 (68.8%)/15 (31.2%) 0.636
Dysphagia
    < Occasionally/≥ every day 4 (25%)/12 (75%) 11 (22.9%)/37 (77.1%) 0.865
Regurgitation n)
    < Occasionally/≥ every day 10 (62.5 %)/6 (37.5%) 31 (64.6%)/17 (35.4%) 0.880
Chest pain (n)
    < Occasionally/≥ every day 12 (75%)/4 (25%) 41 (85.4%)/7 (14.6%) 0.339
Heart burn (n)
    < Occasionally/≥ every day 12 (75%)/4 (25%) 41 (85.4%)/7 (14.6%) 0.339
Dysphagia grade (n)
    1-2/3-5 6 (37.5%)/10 (62.5%) 19 (39.6%)/29 (60.4%) 0.882
Eckardt score (median [IQR]) 5.5 (4-7.8) 4.5 (3-7) 0.407
Esophagram (median [IQR], mm)
    Maximum diameter of the esophageal body 44.0 (38.1-51.5) 44.0 (36.3-53) 0.694
Conventional manometry
    LES pressure (median [IQR], mmHg)b 42.7 (28.1-73) 45.0 (26.9-69) 0.888
High-resolution manometry
    LES pressure (median [IQR], mmHg)c 25.2 (22-25.2) 59 (24-81) 0.393
Esophageal scand
    T1/2 (median [IQR], min)
    R30 (median [IQR], %)
12.3 (5-140.4)
58 (38.8-77.8)
22.6 (4.3-948)
65 (41-87)
0.270
0.572
aStandard dose proton pump inhibitor (PPI) once daily treatment during at least 8 weeks.
bThirty-nine patients were examined by conventional manometry.
cEight patients were examined by high-resolution manometry.
dFifty-seven patients were examined by esophageal scan.
IQR, interquartile range; LES, lower esophageal sphincter; T1/2, half time of esophageal transit scintigraphy; R30, the residual fraction of maximum radioactivity in 
the distal esophagus after 30 seconds.
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other disorders.12 Patients with achalasia frequently complain of re-
gurgitation and heartburn. In untreated patients, postprandial stasis 
and fermentation of food in the esophagus due to impaired esopha-
geal emptying are thought to cause these symptoms.13-15 Addition-
ally, dysphagia is frequently reported by patients with GERD.16 
Therefore, achalasia can be erroneously diagnosed as GERD.
Second, achalasia patients with heartburn were more likely to 
experience weight loss, regurgitation, and chest pain. These patients 
might have more prominent postprandial stasis, fermentation of 
food and poor esophageal clearance, which cause pseudo-gastro-
esophageal reflux.13-15,17 A previous study showed a high prevalence 
of heartburn in achalasia patients, although objective evidence of 
GERD was weak.18 Another study suggested that other processes 
such as esophageal muscle spasm, ischemia, or esophageal disten-
sion might account for the heartburn and chest pain in patients with 
achalasia.19 Weight loss of between 5 and 10 kg occurs in many, but 
not all, achalasia patients. Our patients with heartburn were more 
likely to have weight loss of ≥ 5 kg than those without heartburn. 
Perhaps it is the regurgitation and chest pain that are more likely 
in patients with heartburn, which have a negative influence on the 
dietary intake of achalasia patients.
Third, the median duration of symptoms at the time of di-
agnosis of achalasia was 23.5 months. This is different from the 
findings of several previous studies in which the mean duration of 
symptoms at diagnosis was greater than 4 years.2,20 Achalasia has an 
insidious onset and disease progression is gradual, therefore patients 
typically experience symptoms for years prior to seeking medical 
care. Previous studies concluded that the delay in diagnosis was 
due to misinterpretation as GERD based on typical clinical find-
ings of achalasia. Many patients are treated for GERD before the 
diagnosis of achalasia3,17; indeed, 25% of patients in this study were 
treated with PPIs for relief of symptoms. However, the duration 
of symptoms was shorter in our patient population than in other 
studies, and misdiagnosis as GERD was not a major factor in the 
delay of diagnosis of achalasia. There are several possible reasons 
for these differences. Endoscopy is inexpensive and widely available 
in Korea, even in primary care clinics. Because endoscopy is avail-
able in almost all regions of Korea, other diseases such as GERD 
or esophageal cancer can be excluded on endoscopy. Most patients 
who present with heartburn, epigastric pain, regurgitation, and 
dysphagia initially undergo an endoscopic examination. Further-
more, the medical care and services, including manometry, that are 
provided by tertiary hospitals are very accessible in almost all areas 
of Korea. Consequently, manometry was used early to evaluate pa-
tients with symptoms who had not responded to PPI therapy and 
had non-specific findings on endoscopy. Our findings support the 
medical statement of the American Gastroenterological Association 
that manometry should be used to evaluate patients with suspected 
GERD who do not respond to PPI therapy and have normal find-
ings on endoscopy.21
There are some limitations in this study. First, it was a retro-
spective study in a single tertiary hospital. Second, the sample size 
was relatively small because achalasia is rare, which makes it dif-
ficult to enroll a large population. Third, this study used univariate 
analysis. 
In conclusion, the clinical presentation of patients with untreat-
ed achalasia can show overlap with those of patients with GERD. 
Therefore, these findings suggest that achalasia should be suspected 
in patients with refractory GERD.
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